Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 761460-04-2 | MDL No. : | MFCD23701548 |
Formula : | C13H23NO5 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | ZNKFBXONLAWNSJ-JTQLQIEISA-N |
M.W : | 273.33 | Pubchem ID : | 11254313 |
Synonyms : |
|
Num. heavy atoms : | 19 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 0.85 |
Num. rotatable bonds : | 7 |
Num. H-bond acceptors : | 5.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 73.38 |
TPSA : | 65.07 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.26 cm/s |
Log Po/w (iLOGP) : | 3.28 |
Log Po/w (XLOGP3) : | 0.99 |
Log Po/w (WLOGP) : | 1.19 |
Log Po/w (MLOGP) : | 0.77 |
Log Po/w (SILICOS-IT) : | 1.21 |
Consensus Log Po/w : | 1.49 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.7 |
Solubility : | 5.5 mg/ml ; 0.0201 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.94 |
Solubility : | 3.1 mg/ml ; 0.0114 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -1.62 |
Solubility : | 6.54 mg/ml ; 0.0239 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 3.49 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 839710-38-2 ]
(S)-2-(4-(tert-Butoxycarbonyl)morpholin-3-yl)acetic acid
Similarity: 0.98
[ 104227-71-6 ]
(S)-tert-Butyl (5-oxotetrahydrofuran-3-yl)carbamate
Similarity: 0.88
[ 362703-48-8 ]
1-tert-Butyl 2-ethyl piperidine-1,2-dicarboxylate
Similarity: 0.85
[ 255882-72-5 ]
Methyl 1-Boc-azetidine-2-carboxylate
Similarity: 0.85
[ 180854-44-8 ]
(S)-1-tert-Butyl 2-ethyl 4-oxopiperidine-1,2-dicarboxylate
Similarity: 0.84
[ 104227-71-6 ]
(S)-tert-Butyl (5-oxotetrahydrofuran-3-yl)carbamate
Similarity: 0.88
[ 362703-48-8 ]
1-tert-Butyl 2-ethyl piperidine-1,2-dicarboxylate
Similarity: 0.85
[ 255882-72-5 ]
Methyl 1-Boc-azetidine-2-carboxylate
Similarity: 0.85
[ 180854-44-8 ]
(S)-1-tert-Butyl 2-ethyl 4-oxopiperidine-1,2-dicarboxylate
Similarity: 0.84
[ 164456-75-1 ]
(R)-1-tert-Butyl 2-methyl piperidine-1,2-dicarboxylate
Similarity: 0.83
[ 839710-38-2 ]
(S)-2-(4-(tert-Butoxycarbonyl)morpholin-3-yl)acetic acid
Similarity: 0.98
[ 104227-71-6 ]
(S)-tert-Butyl (5-oxotetrahydrofuran-3-yl)carbamate
Similarity: 0.88
[ 362703-48-8 ]
1-tert-Butyl 2-ethyl piperidine-1,2-dicarboxylate
Similarity: 0.85
[ 255882-72-5 ]
Methyl 1-Boc-azetidine-2-carboxylate
Similarity: 0.85
[ 180854-44-8 ]
(S)-1-tert-Butyl 2-ethyl 4-oxopiperidine-1,2-dicarboxylate
Similarity: 0.84
[ 839710-38-2 ]
(S)-2-(4-(tert-Butoxycarbonyl)morpholin-3-yl)acetic acid
Similarity: 0.98
[ 1257850-82-0 ]
(S)-2-(4-(tert-Butoxycarbonyl)morpholin-2-yl)acetic acid
Similarity: 0.83
[ 500789-41-3 ]
4-tert-Butyl 2-methyl morpholine-2,4-dicarboxylate
Similarity: 0.80
[ 768371-16-0 ]
Ethyl 4-Boc-2-morpholinecarboxylate
Similarity: 0.80
[ 885321-46-0 ]
(R)-4-tert-Butyl 3-methyl morpholine-3,4-dicarboxylate
Similarity: 0.78